Advertisment

Jyothy Labs ad spends up 30.91% to Rs 228.23 crore in FY2024

The parent company of brands such as Ujala, Maxo, Exo, Henko, Pril, Margo, Mr White, T-Shine, Neem, Maya, and MoreLight spent Rs 174.33 crore on ads in FY2023

author-image
BestMediaInfo Bureau
New Update
Jyothy Labs
Listen to this article
0.75x 1x 1.5x
00:00 / 00:00

Delhi: Homegrown FMCG firm Jyothy Labs, which sells brands like Ujala, Maxo, Exo, Henko, Pril, Margo, Mr White, T-Shine, Neem, Maya, and MoreLight increased its adex by 30.91% to Rs 228.23 crore in FY2024 versus Rs 174.33 crore in FY2023.

In Q4 of FY2024, Jyothy Labs adex increased to Rs 59.75 crore from Rs 45.93 crore in the corresponding quarter of the previous year. 

In Q3 FY2024, it spent Rs 60.68 crore.

The FMCG major reported a 31.9% increase in consolidated net profit to Rs 78.15 crore in the March quarter.

The company had posted a consolidated net profit of Rs 59.26 crore in the same quarter a year earlier, Jyothy Labs said in a regulatory filing.

Consolidated revenue from operations in the quarter under review stood at Rs 659.99 crore as against Rs 616.95 crore in the year-ago period.

Total expenses in the quarter were higher at Rs 565.73 crore as compared to Rs 540.71 crore in the corresponding period previous fiscal.

For the fiscal ended March 31, 2024, consolidated net profit was at Rs 369.3 crore as against Rs 239.73 crore in the previous fiscal, the company said.

In FY24, consolidated revenue from operations was at Rs 2,756.93 crore as compared to Rs 2,486.02 crore.

The company, which sells brands like Ujala, Maxo, Exo, Henko, Pril, Margo, Mr White, T-Shine, Neem, Maya, and MoreLight, said its fabric care sales increased 10% for the March quarter over the same period last year and 12.6% for the full year.

Dishwashing sales also increased 6% in Q4FY24 and 8.3% for the full year, while personal care sales increased by 18% in Q4 over the same period last year and 21.1% for the full year.

On the other hand, household insecticide sales were down 9.8% in Q4FY24 and flat for the year due to seasonality impacting the demand, the company said.

"We have delivered a healthy performance for the quarter and for the year with expanding profitability. Our last 4 years have been a consistent double-digit revenue growth with a focus on relentless execution and drive towards higher business scale," Jyothy Labs Chairperson and MD MR Jyothy said.

She said with the rise of disposable incomes, there exists an immense future potential in the categories in which the company is present.

Jyothy Laboratories Limited
Advertisment